from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3400/-

LFCtreatmentdescriptionclass of inhibitor

-0.452

Amikacinug/mL Amikacintranslation

0.380

Cap5-10ug/mL Capreomycintranslation

2.460

Rox10-50 ug/mL Roxithromycintranslation

0.429

SM2-5 ug/mL Streptomycintranslation

-0.185

Tet5-10 ug/mL Tetracyclinetranslation

-0.717

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.099

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.886

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.705

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.766

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.100

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.314

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.101

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.362

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.477

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.153

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.181

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.334

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.377

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.005

KCN5-20 ug/mL Potassium cyaniderespiration

0.551

NaN30.2-2 mM Sodium aziderespiration

0.836

Nigericin50 uM Nigericinrespiration

-0.244

TRC10-150 ug/mL Triclosanrespiration

-1.180

TRZ10-25 ug/mL Thioridazinerespiration

0.695

Valinomycin0.5-10 uM Valinomycinrespiration

-0.047

ZnSO42 mM ZnSO4respiration

0.486

menadione6-10 ug/mL Menadionerespiration

-0.485

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.298

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.453

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.121

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.547

NRP_1Non-replicating persistence stage 1dosRassociated

-0.349

Amp0.2mg/mL AmpicillincellWall

0.011

Cephalexin20-100 ug/mL CephalexincellWall

-0.092

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.301

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.244

EMB10-20 ug/mL EthambutolcellWall

0.001

Eta12-40 ug/mL EthionamidecellWall

-0.006

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.209

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.222

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.723

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.819

BZA0.12 mg/mL BenzamidearomaticAmides

0.496

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.765

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.415

H2O24 mM hydrogen peroxideDNAdamaging

-0.395

Levo10 ug/mL LevofloxacinDNAdamaging

0.111

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.494

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.286

UVUV-irradiationDNAdamaging

-1.361

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.322

Antimycin12.5-50 ug/mL Antimycin A?

-0.174

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.297

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.900

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.135

PA8240.2-2 ug/mL PA-824?

1.326

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.437

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.364

Verapamil50 uM Verapamil?

0.484

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.235

methoxatin10-20 ug/mL Methoxatin?